StockData
Cellectis S.A. logo

Cellectis S.A. (CLLS) stock

CLLSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 20, 2026Score 3/30
$1.03−0.03 (-2.83%)

Close on Nov 18, 2026Market cap $103.35MP/E –Yield –

Cellectis total assets

Total assets on the balance sheet at the end of each period.

Cellectis's total assets was $267.37M at Jun 30, 2026. For fiscal 2025 it was $324.72M, down 15.3% from the year before. Over ten years it grew -1.3% a year on average. The highest annual figure on record is $500.84M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$324.72M-15.3%
FY2024Dec 31, 2024$383.54M+14.7%
FY2023Dec 31, 2023$334.27M+28.0%
FY2022Dec 31, 2022$261.22M-31.6%
FY2021Dec 31, 2021$382.08M-18.6%
FY2020Dec 31, 2020$469.47M+0.4%
FY2019Dec 31, 2019$467.47M-6.7%
FY2018Dec 31, 2018$500.84M+50.5%
FY2017Dec 31, 2017$332.88M+0.4%
FY2016Dec 31, 2016$331.43M-10.7%
FY2015Dec 31, 2015$371.31M+122.2%
FY2014Dec 31, 2014$167.08M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$267.37M-34.3%
Q4 FY2025Dec 31, 2025$324.72M-2.9%
Q2 FY2025Jun 30, 2025$353.97M+68.8%
Q4 FY2024Dec 31, 2024$383.54M+68.5%
Q2 FY2024Jun 30, 2024$407.15M+55.9%
Q4 FY2023Dec 31, 2023$334.27M+4.2%
Q3 FY2023Sep 30, 2023$209.70M-45.1%
Q2 FY2023Jun 30, 2023$227.67M-50.2%
Q4 FY2022Dec 31, 2022$261.22M-44.4%
Q2 FY2022Jun 30, 2022$320.88M-32.1%
Q4 FY2021Dec 31, 2021$382.08M-18.3%
Q2 FY2021Jun 30, 2021$457.57M-8.6%
Q4 FY2020Dec 31, 2020$469.47M+41.0%
Q2 FY2020Jun 30, 2020$472.70M+42.6%
Q4 FY2019Dec 31, 2019$467.47M+25.9%
Q4 FY2018Dec 31, 2018$500.84M+199.8%
Q4 FY2017Dec 31, 2017$332.88M–
Q4 FY2016Dec 31, 2016$331.43M–
Q4 FY2015Dec 31, 2015$371.31M–
Q4 FY2014Dec 31, 2014$167.08M–

More Cellectis figures

See a number that looks wrong?